Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism?

N van Es1, T van der Hulle2, H R Büller1

  • 1Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands.

Insights

A stand-alone D-dimer test below 750 μg/L is proposed to rule out acute pulmonary embolism (PE). However, this study found it unsafe for all patients, with varying negative predictive values across subgroups.

Area of Science:

  • Emergency Medicine
  • Diagnostic Testing
  • Cardiology

Background:

  • A positivity threshold of 750 μg L-1 for stand-alone D-dimer testing has been proposed to rule out acute pulmonary embolism (PE).
  • This approach aims for safe and efficient PE diagnosis without additional imaging.
  • Validation of this diagnostic strategy is necessary.

Purpose of the Study:

  • To evaluate the safety and efficacy of stand-alone D-dimer testing at a 750 μg L-1 threshold for ruling out PE.
  • To determine the negative predictive value (NPV) of this threshold across diverse patient subgroups.

Main Methods:

  • A post-hoc analysis of individual data from 7268 patients with suspected PE across six prospective studies.
  • Patients were stratified using the Wells rule, followed by quantitative D-dimer testing for those with 'PE unlikely' scores.
  • A meta-analytic approach assessed the NPV of D-dimer < 750 μg L-1 overall and in risk subgroups.

Main Results:

  • The pooled incidence of PE was 23%. Overall, 44% of patients had a D-dimer < 750 μg L-1, with a 2.8% PE diagnosis rate (NPV 97.2%).
  • The NPV was highest in low-probability PE patients (99.2%) and lowest in high-probability PE patients (79.3%).
  • NPVs were also reported for patients with active cancer (96.2%), previous venous thromboembolism (94.7%), and inpatients (92.7%).

Conclusions:

  • Stand-alone D-dimer testing at a 750 μg L-1 threshold is not universally safe for ruling out acute PE.
  • The NPV varies significantly across different patient risk profiles.
  • Clinical decisions should consider patient-specific risk factors alongside D-dimer results.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
591
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
587
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.1K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
406
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
445
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
362